Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

337.4200 USD 2.3300 0.69%

As of 15:09:33 ET on 03/03/2015.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 339.6700 High - Low: 339.7400 - 333.9710 Primary Exchange: NASDAQ GM
Volume: 1,461,568 52-Week Range: 207.4800 - 341.4900 Beta vs XNBI: 1.0018

ETF Chart for IBB

No chart data available.
  • IBB:US 337.4300
  • 1D
  • 1M
  • 1Y
339.7500
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / RENE CASIS
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2015-03-02) 339.9300
Assets (M) (on 2015-03-02) 7,988.3020
Shares out (M) 23.50
Market Cap (M) 7,857.69
% Premium -0.05
Average 52-Week % Premium 0.0112
Fund Leveraged N

Dividends for IBB

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.13%

Performance for IBB

1-Month +6.31% 1-Year +28.71%
3-Month +10.71% 3-Year +41.83%
Year To Date +12.00% 5-Year +31.26%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 02/27/2015
Name Position Value % of Total
Biogen Idec Inc 1,885,111 772,122,614 9.721%
Celgene Corp 5,101,878 620,031,233 7.806%
Gilead Sciences Inc 5,781,827 598,592,549 7.537%
Amgen Inc 3,508,766 553,402,574 6.968%
Regeneron Pharmaceuticals Inc 1,163,896 481,666,721 6.064%
Illumina Inc 1,519,318 296,965,896 3.739%
Vertex Pharmaceuticals Inc 2,460,332 293,837,451 3.700%
Alexion Pharmaceuticals Inc 1,488,064 268,402,104 3.379%
Pharmacyclics Inc 942,199 203,449,030 2.562%
BioMarin Pharmaceutical Inc 1,839,315 196,935,457 2.480%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil